Logo image of AIH

AESTHETIC MEDICAL INTERN-ADR (AIH) Stock Price, Quote, News and Overview

NASDAQ:AIH - Nasdaq - US00809M1045 - ADR - Currency: USD

0.3334  -0.17 (-33.19%)

After market: 0.3338 +0 (+0.12%)

AIH Quote, Performance and Key Statistics

AESTHETIC MEDICAL INTERN-ADR

NASDAQ:AIH (5/20/2024, 8:18:23 PM)

After market: 0.3338 +0 (+0.12%)

0.3334

-0.17 (-33.19%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High1.43
52 Week Low0.29
Market Cap15.93M
Shares47.79M
Float47.79M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-03 2024-09-03
IPO10-25 2019-10-25


AIH short term performance overview.The bars show the price performance of AIH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

AIH long term performance overview.The bars show the price performance of AIH in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AIH is 0.3334 USD. In the past month the price decreased by -9.96%. In the past year, price decreased by -62.95%.

AESTHETIC MEDICAL INTERN-ADR / AIH Daily stock chart

AIH Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CI THE CIGNA GROUP 10.97 82.08B
CVS CVS HEALTH CORP 11.71 79.88B
LH LABCORP HOLDINGS INC 17.15 20.84B
DGX QUEST DIAGNOSTICS INC 19.1 19.12B
FMS FRESENIUS MEDICAL CARE-ADR 13.74 13.55B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 148.77 12.18B
DVA DAVITA INC 14.99 11.68B
HIMS HIMS & HERS HEALTH INC 112 10.77B
CHE CHEMED CORP 23.84 8.18B
CRVL CORVEL CORP 25.97 5.57B
OPCH OPTION CARE HEALTH INC 26.89 5.45B
GH GUARDANT HEALTH INC N/A 5.30B

About AIH

Company Profile

AIH logo image Aesthetic Medical International Holdings Group Ltd. engages in the provision of aesthetic medical services. The company is headquartered in Shenzhen, Guangdong and currently employs 1,167 full-time employees. The company went IPO on 2019-10-25. The firm is principally engaged in three businesses. Surgical aesthetic treatments services include eye surgery, rhinoplasty, breast augmentation and liposuction. Non-surgical aesthetic treatments services, which comprise minimally invasive treatments and energy-based treatments such as laser, ultrasound and ultraviolet light treatments. Other aesthetic services include cosmetic dentistry and general medical services. The firm operates its businesses primarily in the domestic market.

Company Info

AESTHETIC MEDICAL INTERN-ADR

4068 Qiaoxiang Road, Nanshan District

Shenzhen GUANGDONG 518052 CN

CEO: Zhou Pengwu

Employees: 1167

Company Website: http://www.pengai.com.cn

Phone: 869176090333

AESTHETIC MEDICAL INTERN-ADR / AIH FAQ

What is the stock price of AESTHETIC MEDICAL INTERN-ADR today?

The current stock price of AIH is 0.3334 USD. The price decreased by -33.19% in the last trading session.


What is the ticker symbol for AESTHETIC MEDICAL INTERN-ADR stock?

The exchange symbol of AESTHETIC MEDICAL INTERN-ADR is AIH and it is listed on the Nasdaq exchange.


On which exchange is AIH stock listed?

AIH stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for AESTHETIC MEDICAL INTERN-ADR stock?

5 analysts have analysed AIH and the average price target is 10.2 USD. This implies a price increase of 2959.39% is expected in the next year compared to the current price of 0.3334. Check the AESTHETIC MEDICAL INTERN-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AESTHETIC MEDICAL INTERN-ADR worth?

AESTHETIC MEDICAL INTERN-ADR (AIH) has a market capitalization of 15.93M USD. This makes AIH a Nano Cap stock.


How many employees does AESTHETIC MEDICAL INTERN-ADR have?

AESTHETIC MEDICAL INTERN-ADR (AIH) currently has 1167 employees.


What are the support and resistance levels for AESTHETIC MEDICAL INTERN-ADR (AIH) stock?

AESTHETIC MEDICAL INTERN-ADR (AIH) has a resistance level at 0.49. Check the full technical report for a detailed analysis of AIH support and resistance levels.


Should I buy AESTHETIC MEDICAL INTERN-ADR (AIH) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AESTHETIC MEDICAL INTERN-ADR (AIH) stock pay dividends?

AIH does not pay a dividend.


When does AESTHETIC MEDICAL INTERN-ADR (AIH) report earnings?

AESTHETIC MEDICAL INTERN-ADR (AIH) will report earnings on 2024-09-03.


What is the Price/Earnings (PE) ratio of AESTHETIC MEDICAL INTERN-ADR (AIH)?

AESTHETIC MEDICAL INTERN-ADR (AIH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.33).


AIH Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AIH. When comparing the yearly performance of all stocks, AIH is a bad performer in the overall market: 93.57% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AIH Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AIH. AIH has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AIH Financial Highlights

Over the last trailing twelve months AIH reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS increased by 89.54% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -13.58%
ROE -178.21%
Debt/Equity 3.91
Chartmill High Growth Momentum
EPS Q2Q%-300%
Sales Q2Q%-4.22%
EPS 1Y (TTM)89.54%
Revenue 1Y (TTM)3.79%

AIH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to AIH. The Buy consensus is the average rating of analysts ratings from 5 analysts.


Ownership
Inst Owners0.04%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price Target10.2 (2959.39%)
EPS Next YN/A
Revenue Next YearN/A